Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division

Cell cycle progression and lipid metabolism are well-coordinated processes required for proper cell proliferation. In liver diseases that arise from dysregulated lipid metabolism, hepatocyte proliferation is diminished. To study the outcome of CDK1 loss and blocked hepatocyte proliferation on lipid...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jin Rong Ow, Matias J Caldez, Gözde Zafer, Juat Chin Foo, Hong Yu Li, Soumita Ghosh, Heike Wollmann, Amaury Cazenave-Gassiot, Chee Bing Ong, Markus R Wenk, Weiping Han, Hyungwon Choi, Philipp Kaldis
Formato: article
Lenguaje:EN
Publicado: eLife Sciences Publications Ltd 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/800dcd51bf63414c82eae688da8bc038
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:800dcd51bf63414c82eae688da8bc038
record_format dspace
spelling oai:doaj.org-article:800dcd51bf63414c82eae688da8bc0382021-11-19T12:15:20ZRemodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division10.7554/eLife.638352050-084Xe63835https://doaj.org/article/800dcd51bf63414c82eae688da8bc0382020-12-01T00:00:00Zhttps://elifesciences.org/articles/63835https://doaj.org/toc/2050-084XCell cycle progression and lipid metabolism are well-coordinated processes required for proper cell proliferation. In liver diseases that arise from dysregulated lipid metabolism, hepatocyte proliferation is diminished. To study the outcome of CDK1 loss and blocked hepatocyte proliferation on lipid metabolism and the consequent impact on whole-body physiology, we performed lipidomics, metabolomics, and RNA-seq analyses on a mouse model. We observed reduced triacylglycerides in liver of young mice, caused by oxidative stress that activated FOXO1 to promote the expression of Pnpla2/ATGL. Additionally, we discovered that hepatocytes displayed malfunctioning β-oxidation, reflected by increased acylcarnitines (ACs) and reduced β-hydroxybutyrate. This led to elevated plasma free fatty acids (FFAs), which were transported to the adipose tissue for storage and triggered greater insulin secretion. Upon aging, chronic hyperinsulinemia resulted in insulin resistance and hepatic steatosis through activation of LXR. Here, we demonstrate that loss of hepatocyte proliferation is not only an outcome but also possibly a causative factor for liver pathology.Jin Rong OwMatias J CaldezGözde ZaferJuat Chin FooHong Yu LiSoumita GhoshHeike WollmannAmaury Cazenave-GassiotChee Bing OngMarkus R WenkWeiping HanHyungwon ChoiPhilipp KaldiseLife Sciences Publications Ltdarticleliverlipid metabolisminsulin resistancehepatic steatosiscell cycleCDK1MedicineRScienceQBiology (General)QH301-705.5ENeLife, Vol 9 (2020)
institution DOAJ
collection DOAJ
language EN
topic liver
lipid metabolism
insulin resistance
hepatic steatosis
cell cycle
CDK1
Medicine
R
Science
Q
Biology (General)
QH301-705.5
spellingShingle liver
lipid metabolism
insulin resistance
hepatic steatosis
cell cycle
CDK1
Medicine
R
Science
Q
Biology (General)
QH301-705.5
Jin Rong Ow
Matias J Caldez
Gözde Zafer
Juat Chin Foo
Hong Yu Li
Soumita Ghosh
Heike Wollmann
Amaury Cazenave-Gassiot
Chee Bing Ong
Markus R Wenk
Weiping Han
Hyungwon Choi
Philipp Kaldis
Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division
description Cell cycle progression and lipid metabolism are well-coordinated processes required for proper cell proliferation. In liver diseases that arise from dysregulated lipid metabolism, hepatocyte proliferation is diminished. To study the outcome of CDK1 loss and blocked hepatocyte proliferation on lipid metabolism and the consequent impact on whole-body physiology, we performed lipidomics, metabolomics, and RNA-seq analyses on a mouse model. We observed reduced triacylglycerides in liver of young mice, caused by oxidative stress that activated FOXO1 to promote the expression of Pnpla2/ATGL. Additionally, we discovered that hepatocytes displayed malfunctioning β-oxidation, reflected by increased acylcarnitines (ACs) and reduced β-hydroxybutyrate. This led to elevated plasma free fatty acids (FFAs), which were transported to the adipose tissue for storage and triggered greater insulin secretion. Upon aging, chronic hyperinsulinemia resulted in insulin resistance and hepatic steatosis through activation of LXR. Here, we demonstrate that loss of hepatocyte proliferation is not only an outcome but also possibly a causative factor for liver pathology.
format article
author Jin Rong Ow
Matias J Caldez
Gözde Zafer
Juat Chin Foo
Hong Yu Li
Soumita Ghosh
Heike Wollmann
Amaury Cazenave-Gassiot
Chee Bing Ong
Markus R Wenk
Weiping Han
Hyungwon Choi
Philipp Kaldis
author_facet Jin Rong Ow
Matias J Caldez
Gözde Zafer
Juat Chin Foo
Hong Yu Li
Soumita Ghosh
Heike Wollmann
Amaury Cazenave-Gassiot
Chee Bing Ong
Markus R Wenk
Weiping Han
Hyungwon Choi
Philipp Kaldis
author_sort Jin Rong Ow
title Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division
title_short Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division
title_full Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division
title_fullStr Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division
title_full_unstemmed Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division
title_sort remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of cdk1 and hepatocyte division
publisher eLife Sciences Publications Ltd
publishDate 2020
url https://doaj.org/article/800dcd51bf63414c82eae688da8bc038
work_keys_str_mv AT jinrongow remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision
AT matiasjcaldez remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision
AT gozdezafer remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision
AT juatchinfoo remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision
AT hongyuli remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision
AT soumitaghosh remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision
AT heikewollmann remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision
AT amaurycazenavegassiot remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision
AT cheebingong remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision
AT markusrwenk remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision
AT weipinghan remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision
AT hyungwonchoi remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision
AT philippkaldis remodelingofwholebodylipidmetabolismandadiabeticlikephenotypecausedbylossofcdk1andhepatocytedivision
_version_ 1718420141940670464